原发性肝癌应用中药联合化疗栓塞术治疗的疗效研究

An effective study on treating primary liver cancer in TCM plus chemoembolization

目的:探究应用中药联合化疗栓塞术治疗原发性肝癌的临床疗效。方法:资料选自2011年8月-2013年8月在本院治疗原发性肝癌的患者68例,随机分为两组,对照组34例应用化疗栓塞术治疗,观察组34例应用中药联合化疗栓塞术治疗,连续治疗2周期(1周期30d),观察两组患者治疗前后近期癌灶变化和生存质量变化的情况。结果:观察组近期癌灶变化总有效率为82.4%,高于对照组的61.8%,观察组原发性肝癌患者治疗后生存质量提高稳定率为94.1%,高于对照组的61.8%,两组比较差异显著,具有统计学意义(P<0.05)。结论:对于原发性肝癌的,采用中药联合化疗栓塞术治疗,临床疗效显著,具有一定的临床实践价值。

Objective：To explore clinical efficacy of TCM plus chemoembolization for primary liver cancer. Methods：68 primary liver cancer patients were randomly divided into two groups, control group of 34 patients were treated with chemoembolization, in observation group, 34 patients were treated with TCM plus chemoembolization treatment, observing before and after treatment foci recent changes and changes in quality of life. Results：The total efficacy of change in recent foci in the observation was 82.4%, higher than 61.8%in the control; improved and stable rates of the quality of life in observation group was 94.1%, higher than 61.8% in the control, the difference was significant （P〈0.05）. Conclusion：For primary liver cancer, TCM combined with chemoembolization has significantl clinical effects and clinical practical value.